Shenzhen Xenotransplantation Medical Engineering Research and Development Center,
Institute of Translational Medicine,
Shenzhen Second People's Hospital,
Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Institute of Translational Medicine, Shenzhen Second People's Hospital
Zhiming Cai has not added Biography.
If you are Zhiming Cai and would like to personalize this page please email our Author Liaison for assistance.
Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis.
BMC cancer Mar, 2014 | Pubmed ID: 24636201
Pyruvate-associated acid resistance in bacteria.
Applied and environmental microbiology Jul, 2014 | Pubmed ID: 24795365
Deficient human β-defensin 1 underlies male infertility associated with poor sperm motility and genital tract infection.
Science translational medicine Aug, 2014 | Pubmed ID: 25122636
Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α.
Acta biochimica et biophysica Sinica Feb, 2015 | Pubmed ID: 25520177
Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637.
Molecular bioSystems May, 2015 | Pubmed ID: 25800227
The potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs.
International journal of molecular sciences Mar, 2015 | Pubmed ID: 25807262
Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Sep, 2015 | Pubmed ID: 25934337
A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinoma.
Journal of translational medicine May, 2015 | Pubmed ID: 25990580
GlnR-Mediated Regulation of ectABCD Transcription Expands the Role of the GlnR Regulon to Osmotic Stress Management.
Journal of bacteriology Oct, 2015 | Pubmed ID: 26170409
A functional variant in the UBE2B gene promoter is associated with idiopathic azoospermia.
Reproductive biology and endocrinology : RB&E Jul, 2015 | Pubmed ID: 26223869
Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Mar, 2016 | Pubmed ID: 26427661
The Golgi-Associated Plant Pathogenesis-Related Protein GAPR-1 Enhances Type I Interferon Signaling Pathway in Response to Toll-Like Receptor 4.
Inflammation Apr, 2016 | Pubmed ID: 26678074
Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Cancer letters 06, 2016 | Pubmed ID: 27018306
Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation.
International journal of molecular sciences Aug, 2016 | Pubmed ID: 27490531
EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9.
The Journal of nutritional biochemistry 03, 2017 | Pubmed ID: 28040581
Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells.
Cancer letters 05, 2018 | Pubmed ID: 29501702
Lentivirus-mediated shRNA targeting inhibits malignant phenotypes of bladder cancer SW780 cells.
OncoTargets and therapy , 2018 | Pubmed ID: 30275714
Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer.
OncoTargets and therapy , 2019 | Pubmed ID: 30863109
LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression.
Bioscience reports 04, 2019 | Pubmed ID: 30902882
Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules.
Cellular and molecular life sciences : CMLS Sep, 2020 | Pubmed ID: 31838573
Recurrent ZNF83-E293V Mutation Promotes Bladder Cancer Progression through the NF-κB Pathway via Transcriptional Dysregulation of S100A8.
Molecular therapy : the journal of the American Society of Gene Therapy 01, 2021 | Pubmed ID: 33002420
Ying Lu*,1,
Shangyou Zou*,1,
Suzanne Bertera*,2,
Rita Bottino2,
David K.C. Cooper3,
Zhengzhao Liu1,
Yi Huang1,
Chengjun Wang1,
Chungu Hong1,
Tian He1,
Hancheng Zhang1,
Qin Huo4,
Hongxing Fu5,
Zhiming Cai1,
Lisha Mou1
1Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Institute of Translational Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, Shenzhen University Health Science Center,
2Institute for Cellular Therapeutics, Allegheny-Singer Research Institute,
3Xenotransplantation Program/Department of Surgery, The University of Alabama at Birmingham,
4College of Life Science and Oceanography, Shenzhen University,
5School of Pharmcy, Wenzhou Medical College
Yuanzheng Peng*,1,
Zhicheng Zou*,1,
Jiao Chen1,
Hancheng Zhang1,
Ying Lu1,
Rito Bittino2,
Hongxing Fu3,
David K. C. Cooper4,
Shan Lin1,
Mengtao Cao1,
Yifan Dai5,
Zhiming Cai1,
Lisha Mou1
1Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Institute of Translational Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Health Science Center,
2Institute for Cellular Therapeutics, Allegheny-Singer Research Institute,
3School of Pharmaceutical Sciences, Wenzhou Medical University,
4Xenotransplantation Program/Department of Surgery, University of Alabama at Birmingham,
5Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University
Ying Lu*,1,2,
Zuhui Pu*,3,
Jiao Chen2,
Jing Deng2,
Ying Deng2,4,
Shufang Zhu2,
Chunliang Xu5,
Fuwen Yao1,2,
Zijing Wu1,2,
Yong Ni1,
Yongqiang Zhan1,
Jun Cheng1,
Naiyang Zhan1,
Wenlong Huang6,
Zhiming Cai2,
Rita Bottino7,
Lisha Mou2
1Department of Hepatopancreatobiliary Surgery, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
2Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Shenzhen Institute of Translational Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
3Imaging Department, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
4Faculty of Science, University of Waterloo,
5School of Life Science, The Chinese University of Hong Kong,
6General Surgery, The First Affiliated Hospital of Shantou University Medical College,
7Director Islet Programs, Imagine Pharma
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados